NATUS MEDICAL INC DEL - COM (NTUS)

Historical Holders from Q1 2014 to Q3 2022

Type / Class: Equity / COM
Symbol: NTUS

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of NATUS MEDICAL INC DEL - COM (NTUS) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2022 Q3	110	$6,000	-$1,063,097,209	$0	$0	$54.55	1
2022 Q2	32,574,569	$1,067,614,289	+$35,099,181	$547,000	$430,000	$32.77	183
2022 Q1	32,099,822	$842,968,404	+$12,947,338		$0	$26.28	164
2021 Q4	31,766,130	$753,863,245	-$39,588,405		$237,000	$23.73	167
2021 Q3	31,663,301	$794,173,880	+$634,311	$0	$0	$25.08	163
2021 Q2	31,512,402	$818,677,304	-$11,907,989	$793,000	$1,840,000	$25.98	166
2021 Q1	31,983,760	$819,217,839	+$20,988,452	$1,388,000	$330,000	$25.61	154
2020 Q4	31,444,134	$630,140,634	+$6,631,227	$1,794,000	$357,000	$20.04	152
2020 Q3	30,950,922	$530,143,775	-$14,965,539	$502,000	$492,000	$17.13	154
2020 Q2	31,314,637	$683,118,383	+$12,240,897	$1,137,000	$2,505,000	$21.82	166
2020 Q1	30,605,294	$707,911,241	-$24,327,315	$1,249,000	$1,408,000	$23.13	160
2019 Q4	31,275,347	$1,031,625,770	+$2,151,224	$997,000	$1,491,000	$32.99	163
2019 Q3	31,349,579	$998,180,967	+$9,084,833	$907,000	$1,665,000	$31.84	162
2019 Q2	31,321,994	$804,658,117	-$1,898,194	$619,000	$1,664,000	$25.69	167
2019 Q1	31,544,336	$800,598,238	-$80,601,005	$1,511,000	$1,911,000	$25.38	164
2018 Q4	33,489,973	$1,139,520,353	+$30,802,608	$17,791,000	$1,940,000	$34.03	168
2018 Q3	32,240,138	$1,149,189,339	-$1,263,828	$2,770,000	$1,757,000	$35.65	171
2018 Q2	32,373,440	$1,116,800,549	+$72,961,117	$2,640,000	$2,177,000	$34.50	168
2018 Q1	30,273,927	$1,018,750,421	-$25,809,110	$2,833,000	$6,256,000	$33.65	181
2017 Q4	31,833,673	$1,216,186,456	+$16,341,817	$3,626,000	$5,581,000	$38.20	206
2017 Q3	31,476,157	$1,180,914,389	+$15,164,415	$12,529,000	$5,325,000	$37.50	195
2017 Q2	31,086,204	$1,159,437,308	-$379,392	$3,331,000	$2,673,000	$37.30	215
2017 Q1	31,013,797	$1,217,178,630	+$208,771,200	$1,763,000	$1,474,000	$39.25	209
2016 Q4	29,661,889	$1,033,148,185	+$49,858,373	$1,773,000	$1,414,000	$34.80	231
2016 Q3	27,885,182	$1,095,213,353	-$47,019,690	$3,261,000	$1,473,000	$39.29	192
2016 Q2	29,214,543	$1,105,420,704	+$12,457,541	$4,612,000	$3,512,000	$37.80	190
2016 Q1	29,202,634	$1,117,308,677	-$53,484,912	$3,247,000	$3,510,000	$38.43	200
2015 Q4	29,709,779	$1,427,565,527	+$20,634,236	$1,984,000	$1,037,000	$48.05	206
2015 Q3	29,668,946	$1,170,406,844	+$12,346,874	$1,353,000	$801,000	$39.45	187
2015 Q2	29,520,149	$1,256,364,050	+$23,115,471	$1,230,000	$1,341,000	$42.56	192
2015 Q1	29,020,592	$1,145,112,711	+$1,993,945	$1,603,000	$276,000	$39.47	202
2014 Q4	29,057,861	$1,047,338,164	+$18,886,722	$1,153,000	$2,303,000	$36.04	202
2014 Q3	29,099,991	$855,780,582	+$29,058,734	$1,850,000	$12,622,000	$29.51	182
2014 Q2	28,237,226	$710,799,187	+$17,388,534	$4,943,000	$23,552,000	$25.14	182
2014 Q1	27,472,398	$708,581,410	+$35,065,078	$9,819,000	$30,566,000	$25.80	177